Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2017-2023
Comunicato Precedente
Comunicato Successivo
The photodynamic therapy market is currently segmented into four divisions of acne, cancer, atherosclerosis and psoriasis with acne and cancer currently leading with majority of research and development being focused in these aspects of the photodynamic therapy due to their steep demand.
Recently, the Photodynamic therapy for various types of cancer like breast cancer, head and neck cancer and lung cancer has been receiving increased attention due to its innovative and noninvasive feature which is currently in high demand globally , that has further led to a steady growth in the photodynamic therapy market.
Key Topics Covered:
1. An Introductory Insight into Photodynamic Cancer Therapy
2. Photodynamic Therapy - A Breakthrough in Modern Cancer Therapy
3. Working Mechanism of the Photodynamic Cancer Therapy- It's Components & Their Role
4. Photosensitizer Delivery - For Increased Efficacy of the Photodynamic Therapy
5. Anti-Tumor Activity of the Photodynamic Therapy
6. Current Status of Various Cancer Treatments Using Photodynamic Therapy
7. Photodynamic Combinational Cancer Therapy- Overcoming Current Cancer Therapy Limitations
8. Recent & Promising Advances in the Photodynamic Therapy Segment
9. Current Market Scenario of the Photodynamic Therapy & its Cognizance in the Oncology Segment
10. Favorable Factors for the Growth of Photodynamic Cancer Therapy Market
11. Challenges to the Photodynamic Therapy Market Growth
12. Anticipation Regarding the Future of Photodynamic Cancer Therapy
13. Global Cancer Photosensitisers Clinical Pipeline by Company & Phase
14. Marketed Cancer Photosensitisers Clinical
15. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/zkm9kj/global_cancer
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
